Tag - IBIO

Feature

Amidst a global pandemic, two biotech companies offer innovative solutions

Since COVID-19 was first identified in China late last year, researchers have been working tirelessly to develop diagnostics, therapeutics and vaccines in an effort to prevent the spread of the SARS-CoV-2 virus. Many...

March 31, 2020

Markets

Dawson James starts CollPlant Biotechnologies at buy; PT $9

Dawson James Securities initiated coverage of CollPlant Biotechnologies (NASDAQ:CLGN) with a “buy” rating and $9 price target. The stock closed at $4.62 on Nov. 1. CollPlant’s technology platform mass produces...

November 4, 2019

Tag - IBIO

Amidst a global pandemic, two biotech companies offer innovative solutions

Dawson James starts CollPlant Biotechnologies at buy; PT $9

Subscribe